74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Imerys SA.
Open
SectorHealthcare
22.06 -0.09
Overview
Share price change
24h
Min
21.74
Max
22.2
Income | 48M -237M |
|---|---|
Sales | 831M 1.7B |
EPS | 0.27 |
Dividend yield | 6.66 |
Profit margin | -14.037 |
Employees | 15,060 |
EBITDA | -140M -63M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +28.66% upside |
Dividend yield Sector Avg | 6.66% 2.54% |
|---|---|
Next Earnings | 30 Oct 2025 |
Market Cap | -1B 1.8B |
|---|---|
Previous open | 22.15 |
Previous close | 22.06 |
News Sentiment
By Acuity
48%
52%
156 / 374 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Imerys SA. Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Imerys SA. Forecast
Price Target
By TipRanks
28.66% upside
12 Months Forecast
Average 29 EUR 28.66%
High 34 EUR
Low 26 EUR
Based on 3 Wall Street analysts offering 12 month price targets forImerys SA. - Dist in the last 3 months.
Sentiment
By Acuity
156 / 374 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Imerys SA.
Imerys S.A. provides mineral-based specialty solutions for various industries worldwide. The company provides additives for paints, coatings, adhesives, caulks, sealants, and rubber; minerals for technical ceramics and traditional ceramics; functional additives for plastics and thermoset; high-performance binders for dry mix mortars and floor screeds; fillers and coatings for paper, board, and packaging applications; filtration agents for liquids and blood plasma; pharmaceutical diluents, coloring agents, processing aids, glidants, and lubricants for tablet production; engineered minerals for cosmetic industry; food additives to preserve flavor; coating agents to improve fertilizer fow; mineral-based cat litters; alumina for high-performance abrasives and graphite in brake pads; and carbon black for conductivity in onboard data systems. The company also offers minerals used to produce high purity silicon metal for electronics and solar panels; graphite and carbon-based solutions for industrial applications; mineral solutions for batteries and energy storage; refractory minerals and solutions for high-temperature processes; and alumina and zirconia for abrasives. It serves construction and infrastructure, consumer and health care, automotive and transportation, energy and electronics, and industry and equipment industries. The company was incorporated in 1880 and is headquartered in Paris, France. The company is a subsidiary of Belgian Securities BV.
